Clinical trial
Inflammation REduction to Prevent cArdiovascular Injury in Renal Disease (REPAIR)
NCT06203977 is registered in ClinicalTrials.gov with Hamilton Health Sciences Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Inflammation REduction to Prevent cArdiovascular Injury in Renal Disease (REPAIR)
- Lead sponsor
- Hamilton Health Sciences Corporation
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 15, 2024
- Completion date
- April 4, 2026
- Enrollment
- 96 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
chronic kidney diseases, renal failure